LUCD · Lucid Diagnostics Inc. · Investor Relations
$0.43
-0.02 (-4.83%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Nov 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying unaudited condensed consolidated financial statements are issued.”View the 10-Q filed Nov 12, 2026
Market Cap
$92.95M
Shares
206.98M
Volume · Nov 16
1.14M
Avg daily vol (3M)
4.99M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-12 | Q3 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-08-13 | Q2 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-08-11 | Canaccord Genuity 46th Annual Growth Conference | Conference |
| 2026-06-24 | 2026 Annual Meeting of Stockholders | Shareholder meeting |
| 2026-05-14 | Q1 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-05-14 | Lucid Diagnostics First Quarter 2026 Business Update | Event |
| 2026-04-16 | 25th Annual Needham Virtual Healthcare Conference | Conference |
| 2026-03-26 | Earnings conference call (announced in 8-K) | Earnings call |
Source: https://ir.luciddx.com/
Key facts
CIK
1799011
CUSIP
54948X109
13F (30d)
77 filings
73 filers
Visit website
Investor relations